Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY

v3.19.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Beginning balance, shares at Dec. 31, 2016   57,618    
Beginning balance, value at Dec. 31, 2016 $ 13,208 $ 6 $ 43,333 $ (30,131)
Shares issued pursuant to conversion of senior convertible promissory notes and accrued interest, shares   8,597    
Shares issued pursuant to conversion of senior convertible promissory notes and accrued interest, value 1,805 $ 1 1,804  
Stock redemptions, shares   398    
Stock redemptions, value 75   75  
Shares issued to settle restricted stock units, shares   2,000    
Shares issued pursuant to CanX acquisition, shares   15,000    
Shares issued pursuant to CanX acquisition, value 0 $ 1 (1)  
Shares issued pursuant to CanX Royalty Buyout, shares   6,400    
Shares issued pursuant to CanX Royalty Buyout, value $ 2,432 $ 1 2,431  
Shares issued for purchase of inventory, shares 500 500    
Shares issued for purchase inventory, value $ 202   202  
Fair value of warrants issued in connection with extinguishment of unsecured note 137   137  
Stock-based compensation 3,419   3,419  
Net income (loss) (4,897)     (4,897)
Ending balance, shares at Dec. 31, 2017   90,513    
Ending balance, value at Dec. 31, 2017 16,381 $ 9 51,400 (35,028)
Shares issued for professional services, shares   225    
Shares issued for professional services, value 295   295  
Issuance of common stock from exercise of stock options, shares   1,489    
Issuance of common stock from exercise of stock options, value 514   514  
Net issuance of common stock from exercise of warrants, shares   2,713    
Stock-based compensation 2,925   2,925  
Net income (loss) 10,001     10,001
Ending balance, shares at Dec. 31, 2018   94,940    
Ending balance, value at Dec. 31, 2018 $ 30,116 $ 9 $ 55,134 $ (25,027)